A critical advance in cancer research is arising with the use of VHH fragments to reactivate damaged p53. This essential malignant suppressor protein is frequently inactivated in several forms of malignancies, leading https://todaybookmarks.com/story22109237/mini-antibodies-restore-tumor-suppressor-p53-new-potential-pathway-for-cancer-treatment